226 related articles for article (PubMed ID: 25789957)
1. Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma.
Gao F; Li X; Geng M; Ye X; Liu H; Liu Y; Wan G; Wang X
Medicine (Baltimore); 2015 Mar; 94(11):e639. PubMed ID: 25789957
[TBL] [Abstract][Full Text] [Related]
2. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma.
Lu SD; Wang YY; Peng NF; Peng YC; Zhong JH; Qin HG; Xiang BD; You XM; Ma L; Li LQ
Medicine (Baltimore); 2016 Feb; 95(5):e2722. PubMed ID: 26844516
[TBL] [Abstract][Full Text] [Related]
5. The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.
Kong W; Xu H; Cheng J; Fang Z; Wang H; Zhang J; Wang X; Dai T; Gao Y
Med Sci Monit; 2020 Jan; 26():e918824. PubMed ID: 31929496
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Unresectable Hepatocellular Carcinoma Treated with Radioembolization.
Sukato DC; Tohme S; Chalhoub D; Han K; Zajko A; Amesur N; Orons P; Marsh JW; Geller DA; Tsung A
J Vasc Interv Radiol; 2015 Jun; 26(6):816-24.e1. PubMed ID: 25824315
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment Inflammation-Based Markers Predict Survival Outcomes in Patients with Early Stage Hepatocellular Carcinoma After Radiofrequency Ablation.
Chu MO; Shen CH; Chang TS; Xu HW; Yen CW; Lu SN; Hung CH
Sci Rep; 2018 Nov; 8(1):16611. PubMed ID: 30413724
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation.
Chen TM; Lin CC; Huang PT; Wen CF
J Gastroenterol Hepatol; 2012 Mar; 27(3):553-61. PubMed ID: 21913982
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation.
Fu SJ; Ji F; Han M; Chen MG; Wang XP; Ju WQ; Zhao Q; Wu LW; Ren QQ; Guo ZY; Wang DP; Zhu XF; Ma Y; He XS
Oncotarget; 2017 Jan; 8(3):4301-4312. PubMed ID: 27935864
[TBL] [Abstract][Full Text] [Related]
11. A combination of the preoperative neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios as a useful predictor of survival outcomes following the transarterial chemoembolization of huge hepatocellular carcinoma.
Liu J; Zhang W; Niu R; Li Y; Zhou X; Han X
Saudi Med J; 2020 Apr; 41(4):376-382. PubMed ID: 32291424
[TBL] [Abstract][Full Text] [Related]
12. Using Pre-Treatment Neutrophil-to-Lymphocyte Ratio to Predict the Prognosis of Young Patients with Hepatocellular Carcinoma Implemented Minimally Invasive Treatment.
Sun S; Wang X; Chen J
J Adolesc Young Adult Oncol; 2020 Feb; 9(1):85-89. PubMed ID: 31621472
[No Abstract] [Full Text] [Related]
13. Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma.
Oh BS; Jang JW; Kwon JH; You CR; Chung KW; Kay CS; Jung HS; Lee S
BMC Cancer; 2013 Feb; 13():78. PubMed ID: 23409924
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of serum gamma-glutamyltransferase levels in patients with hepatocellular carcinoma.
Sun L; Wang R; Gao FY; Li YX; Geng MF; Chen JL; Ye XQ; Li XS; Yang X; Wan G; Yang ZY; Wang XB
Neoplasma; 2017; 64(3):444-452. PubMed ID: 28253724
[TBL] [Abstract][Full Text] [Related]
15. Preablation neutrophil-to-lymphocyte ratio as an independent prognostic factor in locally advanced hepatocellular carcinoma patients following radiofrequency ablation.
Tan W; Sun W; Li X; Zhao L; Wang C; Zang A; Kong X
J Cancer Res Ther; 2018 Jan; 14(1):84-89. PubMed ID: 29516965
[TBL] [Abstract][Full Text] [Related]
16. Are inflammation-based markers useful in patients with hepatocellular carcinoma and clinically significant portal hypertension after liver resection?
Qin L; Li C; Xie F; Wang Z; Wen T
Biosci Trends; 2020 Sep; 14(4):297-303. PubMed ID: 32641640
[TBL] [Abstract][Full Text] [Related]
17. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.
Zhou DS; Xu L; Luo YL; He FY; Huang JT; Zhang YJ; Chen MS
World J Gastroenterol; 2015 May; 21(18):5582-90. PubMed ID: 25987783
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation Therapy.
Lo CH; Lee HL; Hsiang CW; Chiou JF; Lee MS; Chen SW; Shen PC; Lin CS; Chang WC; Yang JF; Dai YH; Chen CY; Chia-Hsien Cheng J; Huang WY
Int J Radiat Oncol Biol Phys; 2021 Feb; 109(2):474-484. PubMed ID: 32898609
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma.
Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Mori K; Uesaka K
Br J Surg; 2016 Jun; 103(7):891-8. PubMed ID: 27005995
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of pretreatment PET/CT lean body mass-corrected parameters in patients with hepatocellular carcinoma.
Sun M; Zhang G; Guo J; Hao S; Wang Z; Fan G
Nucl Med Commun; 2018 Jun; 39(6):564-571. PubMed ID: 29634658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
